Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy of tuberculosis

K L Pinsker, S K Koerner

    American Journal of Hospital Pharmacy
    |March 1, 1976
    PubMed
    Summary

    This review discusses tuberculosis drug treatment, highlighting effective regimens like isoniazid and rifampin. It covers drug choices, toxicity, and special patient considerations for tuberculosis management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group.

    Circulation·1997
    Same author

    Gastric intramural pH in mechanically ventilated patients.

    Thorax·1996
    Same author

    Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.

    Chest·1996
    Same author

    A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

    The New England journal of medicine·1996
    Same author

    Isogravitational heterogeneity of perfusion after unilateral lung transplantation.

    Clinical science (London, England : 1979)·1995
    Same author

    Bronchiolitis obliterans in single-lung transplant recipients.

    Chest·1995

    Area of Science:

    • Infectious Diseases
    • Pharmacology
    • Pulmonary Medicine

    Background:

    • Tuberculosis (TB) remains a significant global health challenge.
    • Effective drug regimens are crucial for TB treatment and control.
    • Understanding drug options and patient factors is key to successful outcomes.

    Purpose of the Study:

    • To review current drug treatment strategies for tuberculosis.
    • To discuss factors influencing the selection of antituberculosis agents and regimens.
    • To summarize the advantages, toxicity, and applications of various TB drugs.

    Main Methods:

    • Literature review of antituberculosis agents and treatment protocols.
    • Discussion of factors affecting drug and regimen selection.
    • Summary of drug toxicities and special therapeutic considerations.

    Main Results:

    • Isoniazid and ethambutol, and isoniazid and rifampin are emphasized as advantageous regimens.
    • Toxicity profiles of key antituberculosis drugs (isoniazid, ethambutol, rifampin, streptomycin) are summarized.
    • The use of second-line drugs, chemoprophylaxis, and adjunctive therapies like corticosteroids are discussed.

    Conclusions:

    • Optimal drug selection and regimen choice are critical for effective tuberculosis treatment.
    • Awareness of drug toxicities and patient-specific factors informs treatment decisions.
    • Comprehensive management includes considering retreatment, chemoprophylaxis, and supportive care.

    Related Experiment Videos